孟祥溪
| Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), | |
| Beijing Key Laboratory of Research, Investigation and Evaluation of Radiopharmaceuticals | |
| Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration) | |
| Department of Nuclear Medicine, | |
| Peking University Cancer Hospital & Institute |
I am currently developing clinical-oriented medical technologies for nuclear medicine and molecular imaging.
The areas of interest include:
| Year | Institution | Position |
|---|---|---|
| 2019.7–2021.7 | Beijing Cancer Hospital | Postdoctoral Research Fellow |
| 2021.7– | Research Assistant Professor |
| Year | Institution | Degree Awarded |
|---|---|---|
| 2009.9–2013.7 | Nankai University | B.S. |
| Tianjin University | B.Eng. | |
| 2013.9–2019.6 | Peking University | |
| 2013.9–2019.8 | Emory University | PhD |
| Georgia Institute of Technology |
| Year | Society | Membership |
|---|---|---|
| 2018–2019 | Chinese Chemical Society | Student member |
| 2018– | Chinese Nuclear Society | Member |
| 2017–2018 | IEEE (Nuclear and Plasma Sciences) | Member |
| 2015– | SNMMI | Member |
| 2013–2014 | Beijing Society Biomedical Engineering | Student member |
echo bWVuZ3hpYW5neGlAcGt1LmVkdS5jbg0K | base64 --decode